Quetiapine in Overdosage
- 1 April 2006
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Therapeutic Drug Monitoring
- Vol. 28 (2), 185-189
- https://doi.org/10.1097/01.ftd.0000185770.44502.51
Abstract
Data on quetiapine overdosage are only sparsely available in the literature. This study provides additional data on the pharmacokinetics and clinical effects of intoxication with this atypical antipsychotic drug. The authors performed a retrospective analysis of all quetiapine intoxications reported to and screened by the toxicological laboratory of the Central Hospital Pharmacy The Hague between January 1999 and December 2003. Cases with known suggested amount of intake and medical outcome were included. From the patient's medical record and from the toxicological laboratory findings, patient demographic characteristics (gender, age), details of quetiapine intoxication (estimated time of ingestion, estimated amount of ingestion, and coingested drugs) and clinical parameters were obtained. Severity of intoxication was graded by the Poisoning Severity Score (PSS). Individual pharmacokinetic parameter values were calculated using a one-compartment open model and a Bayesian fitting procedure. Out of a total of 21 intoxications with quetiapine, 14 fulfilled the inclusion criteria. The ingested dose ranged from 1200 to 18,000 mg. The blood concentration ranged from 1.1 to 8.8 mg/L with a lag time of 1 to 26.2 hours between time of ingestion and blood sampling at the emergency ward. The most frequent findings were somnolence and tachycardia. The PSS was minor in 6 patients (43%), moderate in 5 patients (36%), and severe in 3 patients (21%). Severity of intoxication was not associated with a higher amount of quetiapine intake. The authors found no correlation between the serum concentration of quetiapine and the amount ingested. Elimination t1/2 was not prolonged. It can be concluded that quetiapine intoxications appear to proceed mildly. Tachycardia and somnolence were the main clinical symptoms in our case series. No fatalities occurred. The severity of clinical symptoms was not associated with either a high serum concentration or the suggested amount ingested of quetiapinKeywords
This publication has 10 references indexed in Scilit:
- Quetiapine Serum Concentrations in Psychiatric PatientsTherapeutic Drug Monitoring, 2004
- Quetiapine poisoningAnnals of Emergency Medicine, 2003
- Quetiapine and QTc IssuesPublished by Physicians Postgraduate Press, Inc ,2003
- Death Associated With Quetiapine OverdoseAmerican Journal of Psychiatry, 2002
- Clinical Pharmacokinetics of QuetiapineClinical Pharmacokinetics, 2001
- Quetiapine fumarate overdose: Clinical and pharmacokinetic lessons from extreme conditionsClinical Pharmacology & Therapeutics, 2000
- QT Interval Prolongation Associated With Quetiapine (Seroquel) OverdosePsychosomatics, 2000
- Safety in Overdose of QuetiapinePublished by Physicians Postgraduate Press, Inc ,1998
- An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study)The American Journal of Cardiology, 1992
- MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoringComputers in Biology and Medicine, 1992